Characteristic Bioactive Libraries

These include those focused libraries of small-molecule compounds with their specific applications (Antibiotics Library, CNS-Penetrant Compound Library, DNA Damage & Repair Compound Library, Neural Regeneration Compound Library, PPI Inhibitors Library, etc.).

Cat No.	product name
L5500	Killers Collection	A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS);	277 compounds
T002-00000006	Beta-lactam Compound Library		90 compounds
L1380	Transcription factor targeted Library	Quantity: well-chosen 449 compounds with unique structures targeting transcription factor;	449 compounds
L5510	Drug-induced Liver Injury (DILI) Compound Library	A unique collection of 939 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；	939 compounds
L7700	Neural Regeneration Compound Library	A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;	149 compounds
L9410	Covalent Inhibitor Library	A unique collection of 943 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.	943 compounds
L3100	Hematopoietic Toxicity Compound Library	A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;	104 compounds
L1720	Nucleotide Compound Library	A unique collection of 203 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;	203 compounds
L8000	Stem cell Differentiation Compound Library	A unique collection of 1014 stem cell differentiation signaling targeted compounds for high throughput and high content screening;	1014 compounds
L7900	Osteogenesis-related Compound Library	A unique collection of 100 osteogenesis related compounds for high throughput and high content screening;	100 compounds
L8300	Chromatin Modification Compound Library	A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);	256 compounds
L2400	Endocrinology-Hormones Library	A unique collection of 681 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;	681 compounds
L9600	Peptide Compound Library		440 compounds
L2520	Glycometabolism Compound Library		638 compounds
L5100	Fluorochemical Library	A unique collection of 586 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);	586 compounds
L4900	Cardiotoxicity Compound Library	A unique collection of 132 cardiotoxicity inducing compounds for toxicological study;	132 compounds
L3500	Histone Modification Research Compound Library	A unique collection of 194 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);	194 compounds
L7000	Bioactive Lipid Compound Library	A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsaturated fatty acids, Leukotrienes, lipoxins, LPA & phosphatidic acids, Octadecanoids, PAFs, Prostaglandins & thromboxanes, Retinoids, vitamin D metabolites, Sphingolipids, etc.;	385 compounds
L7500	Coagulation and anticoagulation Compound Library	A unique collection of 153 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);	154 compounds
L5900	CNS-Penetrant Compound Library	A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);	516 compounds
L5800	Selected Impurities Library	A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);	200 compounds
L3980	DNA damage and repair Library Plus	Quantity: well-chosen 667 compounds with unique structures targeting DNA damage & repair;	667 compounds
L4400	Antibiotics Library	A unique collection of 680 compounds with antibiotic activity for new antibacterial drug screening;	680 compounds
T002-00000004	Glutamine Metabolism Compound Library		455 compounds
T002-00000009	Mouse Metabolite Compound Library		203 compounds
L2900	Oxidation-Reduction Compound Library	453 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.	453 compounds
L2510	Lipid Metabolism Compound Library		376 compounds
L2500	Human Endogenous Metabolite Compound Library	A unique collection of 910 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening;	910 compounds
L9500	Target-Focused Phenotypic Screening Library	A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening；	1832 compounds
L9300	Macrocyclic Compounds Library	155 macrocyclic compounds of known activity for high-throughput, high-content screening;	155 compounds
T002-00000008	Gut Microbial Metabolite Library		352 compounds
L9400	PPI Inhibitors Library	A unique collection of 260 PPI-related compounds for drug screening;	260 compounds
L8200	Anti-aging Compound Library	A unique collection of 3050 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);	3050 compounds